Literature DB >> 6617097

Altered behaviour of erythrocytes in scleroderma.

I B Kovacs, S O Sowemimo-Coker, J D Kirby, P Turner.   

Abstract

Filterability (deformability) of erythrocytes of patients with Raynaud's phenomenon together with progressive systemic sclerosis (PSS) was decreased compared with the filtration of erythrocytes from normal subjects. PSS erythrocytes showed lower electrophoretic velocity and about 23% less neuraminidase-removable sialic acid density on their surface than the normal erythrocytes. PSS erythrocytes showed more adherence to cultured endothelial cells than the control normal erythrocytes. It is concluded that the increased rigidity and adherence of PSS erythrocytes may have pathological significance in the mechanism of vascular abnormalities in PSS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6617097     DOI: 10.1042/cs0650515

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

1.  The effect of pentoxifylline on filterability of normal red blood cells and their adhesiveness to cultured endothelial cells.

Authors:  S O Sowemimo-Coker; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.

Authors:  O K Roald; E Seem
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-08

3.  Plasma or serum from patients with systemic sclerosis alters behaviour of normal erythrocytes.

Authors:  I B Kovacs; M H Rustin; R H Thomas; C Ridler; S O Sowemimo-Coker; J D Kirby
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

4.  In vitro and ex vivo effect of hyaluronic acid on erythrocyte flow properties.

Authors:  A Luquita; L Urli; M J Svetaz; A M Gennaro; M E Giorgetti; G Pistone; R Volpintesta; S Palatnik; M Rasia
Journal:  J Biomed Sci       Date:  2010-02-12       Impact factor: 8.410

5.  Effects of verapamil on calcium-induced rigidity and on filterability of red blood cells from healthy volunteers and patients with progressive systemic sclerosis.

Authors:  S O Sowemimo-Coker; I B Kovacs; J D Kirby; P Turner
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.